BIO-Europe Spring® 2013 to be held in Barcelona
EBD Group today announced that the next edition of BIO-Europe Spring® will be in Barcelona, Spain. Leaders from the global biotechnology industry will gather for the seventh annual BIO-Europe Spring partnering conference on March 11–13, 2013 at the CCIB Convention Centre. The event will attract more than 2,100 executives from 1,300 companies representing over 40 countries who will engage in upwards of 11,000 one-to-one partnering meetings.
Almirall, Bayer Schering Pharma and Merck Serono will be among many pharmaceutical companies sponsoring BIO-Europe Spring next year; Amgen, AstraZeneca, Baxter, Crucell, Esteve, Johnson &Johnson, Merck & Co., Inc., Novartis, Nycomed, Palau Pharma, Pfizer, Roche, Sanofi and many other sponsors will also be in attendance and ready to partner.
“We are especially excited to welcome delegates back to Barcelona because we have so many companies reaching a critical point in their development where connecting with the international community is essential to their success,” said Montserrat Vendrell, CEO for Biocat, the organization responsible for coordinating and promoting biotechnology in the BioRegion of Catalonia.
Two years ago at BIO-Europe Spring, companies in Catalonia were primarily focused in the discovery phase, she said, while now half of companies in research and development have advanced to clinical trials.
Currently 242 new therapeutic products are in various stages of development with a significant number in Phase I and II trials.
The backdrop to the conference is Barcelona’s thriving life science community. Organized under the banner of BioRegion of Catalonia, the region has become one the main economic drivers for Spain. Over the past several years this sector has achieved an annual growth rate of 30 percent and now consists of 13 scientific parks and 60 research centers, featuring the National Genome Analysis Center. The center offers applications on 11 state-of-the-art genome sequencing units that include de novo sequencing or resequencing of entire genomes, the identification of DNA binding sites and the sequencing of RNA.
The BIO-Europe Spring program, a hallmark of the event, annually features the leading industry decision makers who take on the most pressing challenges confronting biotech’s future growth and competitiveness. The BIO-Europe Spring program includes Therapeutic Insight by Defined Health, one of the leading strategic bio-pharma business development firms.
Additional links and information:
Follow BIO-Europe Spring 2012 on Twitter: twitter.com/EBDgroup (hashtag: #BES12)
LinkedIn Event site: http://linkd.in/uA0L0x
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
- The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
About BIO-Europe Spring® 2014
As the springtime counterpart to BIO-Europe®, BIO-Europe Spring® continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s acclaimed partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the biotech value chain.
In addition to productive partnering, BIO-Europe Spring offers high level workshops, panels, company presentations, and a lively exhibition. The program features executive level panelists who openly share their insight and opinion on many important industry issues. The company presentation tracks provide a forum for innovative start-ups, established biotech companies, and large and midsize pharma to present information on products, partnering opportunities and corporate strategy.
Combined, these elements create an insightful and productive event that will have you coming back year after year.
BIO-Europe Spring is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Industry Organization (BIO).
Follow BIO-Europe Spring 2014 on Twitter: twitter.com/ebdgroup (hashtag: #BES14). Or log on to the BIO-Europe Spring 2014 Discussion Forum on partnering360. The Group is your go-to discussion forum for news and topics related to BIO-Europe Spring.